A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Emerging research highlights the complexities of cardiovascular medicine, particularly regarding the interplay between genetic predispositions, ...